Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamy Ard

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
BMJ (Clinical Research Ed.)|February 7, 2015
Obesity in the US: what is the best role for primary care?Jamy Ard
The Lancet. Diabetes & Endocrinology|November 28, 2024
The promise and hope of GLP-1 receptor agonistsPriya Sumithran, Jamy Ard
Diabetes, Obesity & Metabolism|August 7, 2024
The latest evidence and clinical guidelines for use of meal replacements in very-low-calorie diets or low-calorie diets for the treatment of obesityShenelle A Edwards-Hampton, Jamy Ard
Journal of the National Medical Association|May 2, 2020
A Call to Action-The Need to Address Obesity in the Black CommunityKathi Earles, Jamy Ard, Fatima Cody Stanford
Frontiers in Public Health|April 16, 2025
Tackling the complexity of obesity in the US through adaptation of public health strategiesJamy Ard, Amber Huett-Garcia, Michele Bildner
Obesity (Silver Spring, Md.)|June 27, 2024
Efficacy and safety of semaglutide 2.4 mg by race and ethnicity: A post hoc analysis of three randomized controlled trialsDomenica Rubino, Hanna Angelene, Anthony Fabricatore, et al.
Diabetes, Obesity & Metabolism|June 13, 2023
Effects of dietary quality, physical activity and weight loss on glucose homeostasis in persons with and without prediabetes in the PREMIER trialVlad Gradinariu, Jamy Ard, Rob M van Dam
Dermatology Online Journal|December 16, 2024
Addressing the cardiovascular implications of acanthosis nigricans: what a dermatologist needs to knowEvan Eggiman, Steve Feldman, Jamy Ard, et al.
Frontiers in Public Health|July 31, 2023
Promise and unrealized potential: 10 years of the American Medical Association classifying obesity as a diseaseLeah M Schumacher, Jamy Ard, David B Sarwer
Advances in Therapy|May 12, 2021
Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor AgonistsJamy Ard, Angela Fitch, Sharon Fruh, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
BMJ (Clinical Research Ed.)|February 7, 2015
Obesity in the US: what is the best role for primary care?Jamy Ard
The Lancet. Diabetes & Endocrinology|November 28, 2024
The promise and hope of GLP-1 receptor agonistsPriya Sumithran, Jamy Ard
Diabetes, Obesity & Metabolism|August 7, 2024
The latest evidence and clinical guidelines for use of meal replacements in very-low-calorie diets or low-calorie diets for the treatment of obesityShenelle A Edwards-Hampton, Jamy Ard
Journal of the National Medical Association|May 2, 2020
A Call to Action-The Need to Address Obesity in the Black CommunityKathi Earles, Jamy Ard, Fatima Cody Stanford
Frontiers in Public Health|April 16, 2025
Tackling the complexity of obesity in the US through adaptation of public health strategiesJamy Ard, Amber Huett-Garcia, Michele Bildner
Obesity (Silver Spring, Md.)|June 27, 2024
Efficacy and safety of semaglutide 2.4 mg by race and ethnicity: A post hoc analysis of three randomized controlled trialsDomenica Rubino, Hanna Angelene, Anthony Fabricatore, et al.
Diabetes, Obesity & Metabolism|June 13, 2023
Effects of dietary quality, physical activity and weight loss on glucose homeostasis in persons with and without prediabetes in the PREMIER trialVlad Gradinariu, Jamy Ard, Rob M van Dam
Dermatology Online Journal|December 16, 2024
Addressing the cardiovascular implications of acanthosis nigricans: what a dermatologist needs to knowEvan Eggiman, Steve Feldman, Jamy Ard, et al.
Frontiers in Public Health|July 31, 2023
Promise and unrealized potential: 10 years of the American Medical Association classifying obesity as a diseaseLeah M Schumacher, Jamy Ard, David B Sarwer
Advances in Therapy|May 12, 2021
Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Receptor AgonistsJamy Ard, Angela Fitch, Sharon Fruh, et al.
Pageof 6